Nenglixin
Integrated circuit design and electronic design automation tools
About Nenglixin
Shanghai Leda Technology Co., Ltd., also known as 立芯 (Lìxīn), is a company specializing in the development of electronic design automation (EDA) tools for integrated circuits. Founded in November 2020 by Dr. Chen Jianli, a professor from Fudan University, the company focuses on creating tools for digital circuit physical design, logic synthesis, and 3DIC/chiplet system design. The name '立芯' signifies the goal of helping China's chip industry to 'stand up'.
Dr. Chen Jianli has a long-standing academic and research background in EDA, specifically in placement algorithms, with over 17 years of experience in the field before starting the company. His transition from academia to industry was driven by a desire to contribute to a self-reliant chip development ecosystem in China. The core team consists of experts from both industry and academia with extensive experience in EDA tool development.
The company's main product is LeCompiler™, a digital design tool that covers the entire RTL-to-GDSII process, focusing on the co-optimization of logic synthesis and place-and-route. This tool has been commercially adopted and validated by clients, showing performance comparable to, and in some cases exceeding, industry benchmarks in terms of timing, congestion, power, and area. Additionally, 立芯 is developing Le3DIC™, a platform for 3D/chiplet system planning, design, and analysis. The business model involves providing these advanced EDA software tools to companies involved in high-end chip design. The company has secured significant funding, including a Series B round of over 200 million yuan, to support product iteration and market expansion.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Jiangbei District, China
- Open positions
- None listed
- Dealroom signal
- 19.7/100
- Industry
- Semiconductors
- Sector
- Semiconductors, Core AI, Chips and Processors, GaN Chips, AI Computing Infrastructure, DT and LS, science-based
- Technology
- Artificial Intelligence, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Jun 2025 | $14M | $55M | Lihe Capital · Fefan Ventures | ↗ |
Growth signals
Latest recorded traffic for Nenglixin is 80 monthly website visits, down 70.4% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- LCLihe Capital
- FVFefan Ventures
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Nenglixin on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nenglixin’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






